Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sequent Scientific Limited ( (IN:SEQUENT) ) has issued an update.
Sequent Scientific Limited and Viyash Lifesciences Private Limited have received approval from the National Company Law Tribunal for their merger, marking a significant transformation in the global animal health market. This merger is expected to create a leading animal health company from India, leveraging synergies to enhance financial performance and capitalize on growth opportunities in the companion animal health segment and the genericization of animal health products. The merger aims to accelerate organic growth, provide financial stability, and enhance capabilities in research and development, positioning the combined entity as a reliable partner in the industry.
More about Sequent Scientific Limited
Sequent Scientific Limited is a prominent player in the global animal health industry, focusing on providing innovative solutions for animal care. The company is involved in the production of pharmaceuticals for animals, with a strong emphasis on research and development to enhance its product offerings.
Average Trading Volume: 90,367
Technical Sentiment Signal: Buy
Current Market Cap: 57.53B INR
For a thorough assessment of SEQUENT stock, go to TipRanks’ Stock Analysis page.